Review pathology in a diagnostic bladder cancer trial: Effect of patient risk category
- 30 April 2006
- Vol. 67 (4) , 751-755
- https://doi.org/10.1016/j.urology.2005.10.028
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- IMPROVED DETECTION AND TREATMENT OF BLADDER CANCER USING HEXAMINOLEVULINATE IMAGING: A PROSPECTIVE, PHASE III MULTICENTER STUDYJournal of Urology, 2005
- A Second-Look TUR in T1 Transitional Cell Carcinoma: Why?European Urology, 2004
- Bladder Carcinoma in Situ in 2003: State of the ArtEuropean Urology, 2004
- Improved Detection of Urothelial Carcinoma In Situ With Hexaminolevulinate Fluorescence CystoscopyJournal of Urology, 2004
- Correlation of Cystoscopy With Histology of Recurrent Papillary Tumors of the BladderJournal of Urology, 2002
- Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladderHuman Pathology, 2001
- THE ROLE AND IMPACT OF PATHOLOGY REVIEW ON STAGE AND GRADE ASSESSMENT OF STAGES TA AND T1 BLADDER TUMORS: A COMBINED ANALYSIS OF 5 EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER TRIALSJournal of Urology, 2000
- The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary BladderThe American Journal of Surgical Pathology, 1998
- The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trialBritish Journal of Urology, 1994
- The clinical epidemiology of superficial bladder cancerBritish Journal of Cancer, 1993